PMC:7212965 / 69587-70485 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T164","span":{"begin":409,"end":414},"obj":"Body_part"}],"attributes":[{"id":"A164","pred":"fma_id","subj":"T164","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":" Qi, 202045Chongqing Public Health Medical Center, Chongqing Three Georges Central Hospital, and Qianjiang Central Hospital of ChongqingChongqingDates: 1/19/2020-2/16/2020Last follow-up: 2/16/2020 n = 267Survival: 1.5% died, 38.6% discharged, 59.9% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR. Excluded patients with missing data (42).Age: M 48 y (IQR, 25–65 y)Sex: 44.2% femalesGI/liver comorbidities: GI diseases 4.5%Disease severity: 81.3% non-severe and 18.7% severe Diarrhea: 3.7% (10)Present on admission7/217 nonsevere and 3/50 severeNausea or vomiting: 2.2% (6)Present on admission5/217 nonsevere and 1/50 severeAnorexia: 17.2% (46)Present on admission33/217 nonsevere and 13/50 severeAbdominal pain: NR AST \u003e35: 7.2% (19)9/217 non-severe and 10/50 severeALT \u003e40: 7.5% (20)10/217 non-severe and 10/50 severeBilirubin \u003e1.5: 2.2% (6)3/217 non-severe and 3/50 severe"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T131","span":{"begin":409,"end":414},"obj":"Body_part"}],"attributes":[{"id":"A131","pred":"uberon_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":" Qi, 202045Chongqing Public Health Medical Center, Chongqing Three Georges Central Hospital, and Qianjiang Central Hospital of ChongqingChongqingDates: 1/19/2020-2/16/2020Last follow-up: 2/16/2020 n = 267Survival: 1.5% died, 38.6% discharged, 59.9% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR. Excluded patients with missing data (42).Age: M 48 y (IQR, 25–65 y)Sex: 44.2% femalesGI/liver comorbidities: GI diseases 4.5%Disease severity: 81.3% non-severe and 18.7% severe Diarrhea: 3.7% (10)Present on admission7/217 nonsevere and 3/50 severeNausea or vomiting: 2.2% (6)Present on admission5/217 nonsevere and 1/50 severeAnorexia: 17.2% (46)Present on admission33/217 nonsevere and 13/50 severeAbdominal pain: NR AST \u003e35: 7.2% (19)9/217 non-severe and 10/50 severeALT \u003e40: 7.5% (20)10/217 non-severe and 10/50 severeBilirubin \u003e1.5: 2.2% (6)3/217 non-severe and 3/50 severe"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T346","span":{"begin":295,"end":303},"obj":"Disease"},{"id":"T347","span":{"begin":498,"end":506},"obj":"Disease"}],"attributes":[{"id":"A346","pred":"mondo_id","subj":"T346","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A347","pred":"mondo_id","subj":"T347","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":" Qi, 202045Chongqing Public Health Medical Center, Chongqing Three Georges Central Hospital, and Qianjiang Central Hospital of ChongqingChongqingDates: 1/19/2020-2/16/2020Last follow-up: 2/16/2020 n = 267Survival: 1.5% died, 38.6% discharged, 59.9% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR. Excluded patients with missing data (42).Age: M 48 y (IQR, 25–65 y)Sex: 44.2% femalesGI/liver comorbidities: GI diseases 4.5%Disease severity: 81.3% non-severe and 18.7% severe Diarrhea: 3.7% (10)Present on admission7/217 nonsevere and 3/50 severeNausea or vomiting: 2.2% (6)Present on admission5/217 nonsevere and 1/50 severeAnorexia: 17.2% (46)Present on admission33/217 nonsevere and 13/50 severeAbdominal pain: NR AST \u003e35: 7.2% (19)9/217 non-severe and 10/50 severeALT \u003e40: 7.5% (20)10/217 non-severe and 10/50 severeBilirubin \u003e1.5: 2.2% (6)3/217 non-severe and 3/50 severe"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T512","span":{"begin":369,"end":371},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T513","span":{"begin":409,"end":414},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T514","span":{"begin":409,"end":414},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T515","span":{"begin":744,"end":746},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"}],"text":" Qi, 202045Chongqing Public Health Medical Center, Chongqing Three Georges Central Hospital, and Qianjiang Central Hospital of ChongqingChongqingDates: 1/19/2020-2/16/2020Last follow-up: 2/16/2020 n = 267Survival: 1.5% died, 38.6% discharged, 59.9% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR. Excluded patients with missing data (42).Age: M 48 y (IQR, 25–65 y)Sex: 44.2% femalesGI/liver comorbidities: GI diseases 4.5%Disease severity: 81.3% non-severe and 18.7% severe Diarrhea: 3.7% (10)Present on admission7/217 nonsevere and 3/50 severeNausea or vomiting: 2.2% (6)Present on admission5/217 nonsevere and 1/50 severeAnorexia: 17.2% (46)Present on admission33/217 nonsevere and 13/50 severeAbdominal pain: NR AST \u003e35: 7.2% (19)9/217 non-severe and 10/50 severeALT \u003e40: 7.5% (20)10/217 non-severe and 10/50 severeBilirubin \u003e1.5: 2.2% (6)3/217 non-severe and 3/50 severe"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T71467","span":{"begin":430,"end":432},"obj":"Chemical"},{"id":"T5327","span":{"begin":736,"end":738},"obj":"Chemical"},{"id":"T71182","span":{"begin":739,"end":742},"obj":"Chemical"}],"attributes":[{"id":"A2020","pred":"chebi_id","subj":"T71467","obj":"http://purl.obolibrary.org/obo/CHEBI_73907"},{"id":"A10379","pred":"chebi_id","subj":"T5327","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A13551","pred":"chebi_id","subj":"T71182","obj":"http://purl.obolibrary.org/obo/CHEBI_76649"}],"text":" Qi, 202045Chongqing Public Health Medical Center, Chongqing Three Georges Central Hospital, and Qianjiang Central Hospital of ChongqingChongqingDates: 1/19/2020-2/16/2020Last follow-up: 2/16/2020 n = 267Survival: 1.5% died, 38.6% discharged, 59.9% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR. Excluded patients with missing data (42).Age: M 48 y (IQR, 25–65 y)Sex: 44.2% femalesGI/liver comorbidities: GI diseases 4.5%Disease severity: 81.3% non-severe and 18.7% severe Diarrhea: 3.7% (10)Present on admission7/217 nonsevere and 3/50 severeNausea or vomiting: 2.2% (6)Present on admission5/217 nonsevere and 1/50 severeAnorexia: 17.2% (46)Present on admission33/217 nonsevere and 13/50 severeAbdominal pain: NR AST \u003e35: 7.2% (19)9/217 non-severe and 10/50 severeALT \u003e40: 7.5% (20)10/217 non-severe and 10/50 severeBilirubin \u003e1.5: 2.2% (6)3/217 non-severe and 3/50 severe"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T318","span":{"begin":498,"end":506},"obj":"Phenotype"},{"id":"T319","span":{"begin":578,"end":586},"obj":"Phenotype"},{"id":"T320","span":{"begin":730,"end":734},"obj":"Phenotype"}],"attributes":[{"id":"A318","pred":"hp_id","subj":"T318","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A319","pred":"hp_id","subj":"T319","obj":"http://purl.obolibrary.org/obo/HP_0002013"},{"id":"A320","pred":"hp_id","subj":"T320","obj":"http://purl.obolibrary.org/obo/HP_0012531"}],"text":" Qi, 202045Chongqing Public Health Medical Center, Chongqing Three Georges Central Hospital, and Qianjiang Central Hospital of ChongqingChongqingDates: 1/19/2020-2/16/2020Last follow-up: 2/16/2020 n = 267Survival: 1.5% died, 38.6% discharged, 59.9% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR. Excluded patients with missing data (42).Age: M 48 y (IQR, 25–65 y)Sex: 44.2% femalesGI/liver comorbidities: GI diseases 4.5%Disease severity: 81.3% non-severe and 18.7% severe Diarrhea: 3.7% (10)Present on admission7/217 nonsevere and 3/50 severeNausea or vomiting: 2.2% (6)Present on admission5/217 nonsevere and 1/50 severeAnorexia: 17.2% (46)Present on admission33/217 nonsevere and 13/50 severeAbdominal pain: NR AST \u003e35: 7.2% (19)9/217 non-severe and 10/50 severeALT \u003e40: 7.5% (20)10/217 non-severe and 10/50 severeBilirubin \u003e1.5: 2.2% (6)3/217 non-severe and 3/50 severe"}

{"project":"LitCovid-sentences","denotations":[{"id":"T593","span":{"begin":0,"end":151},"obj":"Sentence"},{"id":"T594","span":{"begin":152,"end":186},"obj":"Sentence"},{"id":"T595","span":{"begin":187,"end":213},"obj":"Sentence"},{"id":"T596","span":{"begin":214,"end":278},"obj":"Sentence"},{"id":"T597","span":{"begin":279,"end":320},"obj":"Sentence"},{"id":"T598","span":{"begin":321,"end":366},"obj":"Sentence"},{"id":"T599","span":{"begin":367,"end":392},"obj":"Sentence"},{"id":"T600","span":{"begin":393,"end":463},"obj":"Sentence"},{"id":"T601","span":{"begin":464,"end":507},"obj":"Sentence"},{"id":"T602","span":{"begin":508,"end":587},"obj":"Sentence"},{"id":"T603","span":{"begin":588,"end":656},"obj":"Sentence"},{"id":"T604","span":{"begin":657,"end":747},"obj":"Sentence"},{"id":"T605","span":{"begin":748,"end":798},"obj":"Sentence"},{"id":"T606","span":{"begin":799,"end":857},"obj":"Sentence"},{"id":"T607","span":{"begin":858,"end":898},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Qi, 202045Chongqing Public Health Medical Center, Chongqing Three Georges Central Hospital, and Qianjiang Central Hospital of ChongqingChongqingDates: 1/19/2020-2/16/2020Last follow-up: 2/16/2020 n = 267Survival: 1.5% died, 38.6% discharged, 59.9% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR. Excluded patients with missing data (42).Age: M 48 y (IQR, 25–65 y)Sex: 44.2% femalesGI/liver comorbidities: GI diseases 4.5%Disease severity: 81.3% non-severe and 18.7% severe Diarrhea: 3.7% (10)Present on admission7/217 nonsevere and 3/50 severeNausea or vomiting: 2.2% (6)Present on admission5/217 nonsevere and 1/50 severeAnorexia: 17.2% (46)Present on admission33/217 nonsevere and 13/50 severeAbdominal pain: NR AST \u003e35: 7.2% (19)9/217 non-severe and 10/50 severeALT \u003e40: 7.5% (20)10/217 non-severe and 10/50 severeBilirubin \u003e1.5: 2.2% (6)3/217 non-severe and 3/50 severe"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2246","span":{"begin":330,"end":338},"obj":"Species"},{"id":"2426","span":{"begin":295,"end":303},"obj":"Disease"},{"id":"2427","span":{"begin":430,"end":441},"obj":"Disease"},{"id":"2428","span":{"begin":498,"end":506},"obj":"Disease"},{"id":"2429","span":{"begin":578,"end":586},"obj":"Disease"},{"id":"2430","span":{"begin":714,"end":734},"obj":"Disease"}],"attributes":[{"id":"A2246","pred":"tao:has_database_id","subj":"2246","obj":"Tax:9606"},{"id":"A2426","pred":"tao:has_database_id","subj":"2426","obj":"MESH:C000657245"},{"id":"A2427","pred":"tao:has_database_id","subj":"2427","obj":"MESH:D005767"},{"id":"A2428","pred":"tao:has_database_id","subj":"2428","obj":"MESH:D003967"},{"id":"A2429","pred":"tao:has_database_id","subj":"2429","obj":"MESH:D014839"},{"id":"A2430","pred":"tao:has_database_id","subj":"2430","obj":"MESH:D010146"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" Qi, 202045Chongqing Public Health Medical Center, Chongqing Three Georges Central Hospital, and Qianjiang Central Hospital of ChongqingChongqingDates: 1/19/2020-2/16/2020Last follow-up: 2/16/2020 n = 267Survival: 1.5% died, 38.6% discharged, 59.9% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR. Excluded patients with missing data (42).Age: M 48 y (IQR, 25–65 y)Sex: 44.2% femalesGI/liver comorbidities: GI diseases 4.5%Disease severity: 81.3% non-severe and 18.7% severe Diarrhea: 3.7% (10)Present on admission7/217 nonsevere and 3/50 severeNausea or vomiting: 2.2% (6)Present on admission5/217 nonsevere and 1/50 severeAnorexia: 17.2% (46)Present on admission33/217 nonsevere and 13/50 severeAbdominal pain: NR AST \u003e35: 7.2% (19)9/217 non-severe and 10/50 severeALT \u003e40: 7.5% (20)10/217 non-severe and 10/50 severeBilirubin \u003e1.5: 2.2% (6)3/217 non-severe and 3/50 severe"}